Fig. 5

Perceived treatment satisfaction in the SCIg naïve and SCIg switch subgroups. A Transformed TSQM-9 effectiveness domain scores and B raw scores from the corresponding TSQM-9 domain items. C Transformed TSQM-9 convenience domain scores and D raw scores from the corresponding TSQM-9 domain items. E Transformed TSQM-9 global satisfaction domain scores and F raw scores from the corresponding TSQM-9 domain items. *n numbers vary due to missing respondent data for various survey questions. Transformed domain scores are on a 0–100 scale from worst to best and the raw scores are on a one to five or seven scale from extremely dissatisfied to extremely satisfied. Continuous variables were compared using an unpaired t-test and the significant p values are in bold. †Domain items rated on a scale from 1–5. IVIg intravenous immunoglobulin, SCIg subcutaneous immunoglobulin, SD standard deviation, TSQM-9 treatment satisfaction questionnaire for medication 9